NoBACZ products are now available in New Zealand
GLA Pharma and NoBACZ Healthcare Announce Distribution Partnership in New Zealand
GLA Pharma, a well-respected name in New Zealand’s animal health sector, and NoBACZ Healthcare, an innovator in wound management solutions, are delighted to announce a new partnership. GLA Pharma will now be an exclusive distributor of NoBACZ’s livestock and equine products bringing them to New Zealand.
NoBACZ’s cutting-edge products are developed using their unique patented mineral-polymer-technology combining a natural polymer and mineral salts. They are topically applied gels or liquids that set rapidly upon application, providing a waterproof barrier: keeping environmental pathogens and contaminants out while providing a protected environment for the lesion. This innovative and patented technology, originating from the University of Cambridge, offers a versatile formulation approach to meet various needs. NoBACZ’s robust, adhesive ‘second skin’ barriers repel mud, water, detritus, and bacteria. They are intuitive and user-friendly; they self-degrade over time and are environmentally friendly.
UMBIREZ™ and AMBUGREEN™ redefine protection by providing traditional cleansing with a lasting environmental barrier. Antibiotic-free, consisting of food-and-feed grade materials, combined with essential metal ions, in a surgical spirit base UMBIREZ™ and AMBUGREEN™ have widespread application. UMBIREZ™ as a proven superior alternative to iodine for the navels of neonatal livestock, ears and ear tags and AMBUGREEN™ for a variety of uses in all species, including hooves, surgical sites, and broken skin. They offer long-lasting protection and are designed to be tough enough to withstand farm conditions.
GLA Pharma are 100 % New Zealand owned and operated, and an experienced importer and distributor of animal health products. GLA Pharma proudly hold exclusive distribution agreements with several key international manufacturers. With significant veterinary experience behind them, their mission is to bring products and services that can make a real difference to vets in practice and care of animals in New Zealand through a customer-centric approach, with a large focus on teaching and training both vets and their clients.
Together, GLA Pharma and NoBACZ are poised to bring these innovative, new animal healthcare solutions to the New Zealand market, reducing antimicrobial use and ensuring enhanced animal health and welfare through superior protection.
David Charles, International Business Development Manager at NoBACZ said: “We are delighted to enter this partnership with Peter Blaikie and his team at GLA Pharma, which will introduce the NoBACZ Healthcare product range into New Zealand with its formidable livestock sector, and appetite to be at the cutting-edge of new animal health innovations.
Working with GLA Pharma will allow us to provide unique new products into New Zealand, whilst working alongside an experienced in-country team to educate vets and their clients; with the combined goal of supporting improvements in animal health and welfare and reducing antimicrobial use.”
Peter Blaikie founder & CEO at GLA Pharma said; “This is an exciting step in reducing anti-microbial use on farm while providing clinically proven solutions for navel and wound management. Being a veterinarian myself it is essential that any product GLA distribute has both strong science behind it as well as being effective. Having been developed by the University of Cambridge, NoBACZ ticks those boxes!”
For more information, please contact:
GLA Pharma:
info@glapharma.co.nz
NoBACZ:
d.charles@nobacz.com
This partnership signals a significant step forward in providing innovative and reliable healthcare solutions to animal health sector in New Zealand.
